Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Sep;56(9):4994-5; author reply 4996.
doi: 10.1128/AAC.01009-12.

Breakthrough bacteremia due to extended-spectrum-β-lactamase-producing Klebsiella pneumoniae during combination therapy with colistin and tigecycline

Comment

Breakthrough bacteremia due to extended-spectrum-β-lactamase-producing Klebsiella pneumoniae during combination therapy with colistin and tigecycline

Sun Young Cho et al. Antimicrob Agents Chemother. 2012 Sep.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Albur M, Noel A, Bowker K, Macgowan A. 2012. Bactericidal activity of multiple combinations of tigecycline and colistin against NDM-1-producing Enterobacteriaceae. Antimicrob. Agents Chemother. 56:3441–3443 - PMC - PubMed
    1. Bercot B, Poirel L, Dortet L, Nordmann P. 2011. In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae. J. Antimicrob. Chemother. 66:2295–2297 - PubMed
    1. Principe L, D'Arezzo S, Capone A, Petrosillo N, Visca P. 2009. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Ann. Clin. Microbiol. Antimicrob. 8:18 doi:10.1186/1476-0711-8-18 - DOI - PMC - PubMed
    1. Sands M, McCarter Y, Sanchez W. 2007. Synergy testing of multidrug resistant Acinetobacter baumanii against tigecycline and polymyxin using an E-test methodology. Eur. J. Clin. Microbiol. Infect. Dis. 26:521–522 - PubMed
    1. Scheetz MH, et al. 2007. In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:1621–1626 - PMC - PubMed

MeSH terms